Recent developments in litigation over race-based kidney transplant policies have been fueled by newly public deposition testimony from a Swedish transplant executive. The executive revealed that an updated policy continues to reference outdated kidney-function formulas, a revelation that could significantly impact ongoing legal battles.
This testimony underscores a central issue in lawsuits challenging the way hospitals have implemented these race-related calculations. Plaintiffs in these cases argue that the use of race-based criteria in determining kidney function could lead to biased treatment decisions against Black patients. In particular, the outdated formulas could potentially impose undue burdens on Black patients, who may face additional hurdles to prove their eligibility for transplants. More details on this can be found in the Law.com article.
The use of race in medical calculations has been a subject of debate in the medical community. Critics argue that race is too crude a measure and is not a precise proxy for genetic differences that might affect health. Recent policy revisions in major medical institutions aim to address these concerns by transitioning towards more individualized assessments. For instance, the National Kidney Foundation and the American Society of Nephrology have advocated for the removal of race modifiers in calculating estimated glomerular filtration rate (eGFR), a key measure of kidney function. Their joint initiative is helping to develop new guidelines that could influence clinical practices nationwide.
While the deposition may bolster the plaintiffs’ cases, legal experts suggest that proving discrimination in medical decision-making remains a complex task. Hospitals argue that they have acted in accordance with prevailing medical guidelines, which historically included race as a factor in certain clinical algorithms. The challenge for the courts will be to assess whether these practices had discriminatory effects and to determine whether hospitals acted negligently or merely followed established procedures.
The implications of these lawsuits extend beyond the specific policies in question, touching on broader themes of racial bias and equity in healthcare. The potential consequences also raise questions about how hospitals should update their practices to reflect evolving understandings of race in medical science. Legal observers will be closely watching the proceedings for insights into how the judiciary may approach the intricate intersection of race and health policy in the future.